Quantinno Capital Management’s GSK GSK Stock Holding History

Quantinno Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3M	Buy	424,762 +54,244	+15%	+$2.87M	0.03%	680
2026 Q1	$20.4M	Buy	370,518 +48,829	+15%	+$2.65M	0.03%	609
2025 Q4	$15.8M	Buy	321,689 +71,471	+29%	+$3.33M	0.03%	608
2025 Q3	$10.8M	Buy	250,218 +61,125	+32%	+$2.39M	0.03%	636
2025 Q2	$7.26M	Buy	189,093 +61,358	+48%	+$2.34M	0.03%	660
2025 Q1	$4.95M	Buy	127,735 +20,982	+20%	+$768K	0.03%	655
2024 Q4	$3.61M	Buy	106,753 +6,948	+7%	+$250K	0.04%	611
2024 Q3	$4.08M	Sell	99,805 -2,880	-3%	-$118K	0.05%	449
2024 Q2	$3.95M	Buy	102,685 +8,041	+8%	+$338K	0.07%	321
2024 Q1	$4.06M	Buy	94,644 +10,642	+13%	+$439K	0.09%	256
2023 Q4	$3.11M	Buy	84,002 +17,792	+27%	+$639K	0.11%	227
2023 Q3	$2.4M	Buy	66,210 +49,367	+293%	+$1.75M	0.11%	234
2023 Q2	$600K	Buy	16,843 +3,211	+24%	+$115K	0.03%	576
2023 Q1	$485K	Buy	13,632 +1,515	+13%	+$53K	0.03%	585
2022 Q4	$426K	Buy	+12,117	New	+$404K	0.03%	583

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quantinno Capital Management's GSK Position: Q2 2026 in Review

Quantinno Capital Management increased its GSK (GSK) stake by 15% in Q2 2026, buying an estimated $2.87M and bringing the position to 424,762 shares worth $22.3M. The position accounts for 0.03% of the portfolio, ranked #680.

Quantinno Capital Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Quantinno Capital Management held 424,762 shares of GSK worth $22.3M as of Q2 2026.
Quantinno Capital Management bought 54,244 GSK shares in Q2 2026, an estimated $2.87M.
GSK made up 0.03% of Quantinno Capital Management's portfolio in Q2 2026, its #680 holding.
Quantinno Capital Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.